WEDNESDAY, June 30, 2021 (HealthDay News) — Because they’re often given drugs that suppress their immune systems, people battling a blood cancer known as multiple myeloma have varying responses to the COVID-19 vaccine, new research shows. Some patients had no evidence at all of COVID-fighting antibody production after getting twoContinue Reading
MONDAY, June 28, 2021 (HealthDay News) — Early symptoms of multiple sclerosis may commonly be missed for years before the right diagnosis is made, a new study suggests. Researchers found that patients with MS had a higher-than-average number of medical appointments, with doctors of various specialties, for up to fiveContinue Reading
TUESDAY, June 22, 2021 (HealthDay News) — The brains of people who died from COVID-19 were remarkably similar to the brains of people who die from neurodegenerative diseases such as Alzheimer’s and Parkinson’s, showing inflammation and disrupted circuitry, researchers report. “The brains of patients who died from severe COVID-19 showedContinue Reading
FRIDAY, June 18, 2021 (HealthDay News) – A diet designed to boost brain health appears to benefit people with multiple sclerosis (MS), new research suggests. For the study, a team from Icahn School of Medicine at Mount Sinai in New York City examined 185 people diagnosed with MS within theContinue Reading
THURSDAY, June 3, 2021 (HealthDay News) — Parkinson’s disease patients can get symptom relief with deep brain stimulation (DBS) therapy that lasts over the long term, a new study shows. Over 15 years, patients who received DBS, which requires surgical implantation, had significant improvement in motor symptoms and less needContinue Reading
THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading
WEDNESDAY, May 26, 2021 (HealthDay News) — A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “OurContinue Reading
FRIDAY, May 21, 2021 (HealthDay News) — A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition — eczema. In two phase 3 clinical trials, patients with moderate to severe eczema showed rapid and significant improvements after taking the drug, said researchers atContinue Reading
THURSDAY, May 20, 2021 (HealthDay News) — A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say. Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% takeContinue Reading
TUESDAY, May 18, 2021 (HealthDay News) — New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say. Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one inContinue Reading